what is the half-life of bpc 157 BPC-157 10 questions to ask your

8 Conclusion Ang II, the main effector peptide of the RAS, increases arterial pressure through arterioral vasoconstriction and by decreasing renal salt and water excretion through extrarenal and intrarenal mechanisms

10.1371/journal.pmed.1000097 37 NIHR (2025)

Increases Red Blood Cells.4

Subacute and chronic injuries predominantly feature demyelination of the nervous system and megaloblastic anemia, with up to 96% of patients experiencing neurological damage (Oussalah et al., 2019

There is no FDA-approved indication for any patient population

Effective dose with no/minimal side effects: Maintain the current dose for the next 4 weeks